Bottom line
VHT vs FHLC: the short answer
VHT (Vanguard Health Care Index Fund) and FHLC (Fidelity MSCI Health Care Index ETF) have nearly the same top holdings — their top 25 positions are about 94% the same by weight.
FHLC is cheaper at 0.084% vs 0.09% — a difference of $0.60 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +7.2% for FHLC (reporting dates differ).
Updated Nov 19, 2026
VHT vs FHLC side by side
| VHT | FHLC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Vanguard | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.084% |
| Annual cost per $10k | $9 | $8.4 |
| 10-yr cost on $10k (prospectus) | $115 | $108 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.7% | +2.6% |
| 5-yr return (annualized) | +7.2% | +7.2% |
| 10-yr return (annualized) | +8.8% | +8.8% |
| Best quarter | +16.5% | +16.4% |
| Worst quarter | −13.1% | −13.1% |
| Net assets (fund) | $19.0B | $3.3B |
| Number of holdings | 407 | 337 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2024 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHT | FHLC | Difference |
|---|---|---|---|
| 2024 | +2.7% | +2.6% | +0.1% |
| 2023 | +2.5% | +2.5% | −0.0% |
| 2022 | −5.5% | −5.5% | −0.1% |
| 2021 | +20.5% | +20.4% | +0.1% |
| 2020 | +18.2% | +18.1% | +0.1% |
| 2019 | +22.0% | +21.9% | +0.0% |
| 2018 | +5.6% | +5.5% | +0.0% |
| 2017 | +23.3% | +23.3% | +0.0% |
| 2016 | −3.3% | −3.3% | 0.0% |
| 2015 | +7.2% | +7.0% | +0.2% |
Source: Fund prospectus bar charts
Holdings overlap
23 of VHT's top 25 holdings also appear in FHLC's top 25.
| Holding | VHT | FHLC |
|---|---|---|
| Eli Lilly & Co | 14.04% | 13.35% |
| Johnson & Johnson | 8.47% | 8.93% |
| AbbVie Inc | 6.09% | 6.42% |
| UnitedHealth Group Inc | 5.45% | 5.44% |
| Merck & Co Inc | 4.66% | 4.66% |
| Thermo Fisher Scientific Inc | 2.93% | 3.09% |
| Amgen Inc | 2.87% | 3.00% |
| Gilead Sciences Inc | 2.64% | 2.34% |
| Intuitive Surgical Inc | 2.38% | 1.82% |
| Pfizer Inc | 2.35% | 2.06% |
| Abbott Laboratories | 2.35% | 2.66% |
| Bristol-Myers Squibb Co | 1.84% | 1.93% |
| Danaher Corp | 1.84% | 1.80% |
| CVS Health Corp | 1.83% | 1.92% |
| Vertex Pharmaceuticals Inc | 1.80% | 1.76% |
Source: SEC Form N-PORT
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between VHT and FHLC?
Which is cheaper, VHT or FHLC?
Should I own both VHT and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.